MFDS
- Status: likely_approved
🇰🇷 Md-76R in South Korea
Md-76R (Diatrizoate) regulatory status in South Korea.
Marketing authorisation
Md-76R in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in South Korea
Frequently asked questions
Is Md-76R approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Md-76R in South Korea?
University of California, San Francisco is the originator. The local marketing authorisation holder may differ — check the official source linked above.